hat
Lòt efè segondè gen ladan yo ogmante risk pou pwoblèm kè nan pi gran gason ak mobilite pòv, selon yon etid 2009 nan Boston Medical Center. Yon etid 2017 pibliye nan JAMA te jwenn ke tretman ogmante volim kowonè volim plak. Anplis de sa, Administrasyon Manje ak Dwòg (FDA) egzije fabrikasyon pou enkli yon avi sou etikèt la ki deklare ke tretman testostewòn ka lakòz risk posib pou atak kè ak kou. FDA rekòmande ke pasyan ki itilize testostewòn ta dwe chèche atansyon medikal touswit si yo gen sentòm sa yo:
eng
Other side effects include increased risk of heart problems in older men with poor mobility, according to a 2009 study at Boston Medical Center. A 2017 study published in JAMA found that treatments increase coronary artery plaque volume. Additionally, the Food and Drug Administration (FDA) requires manufactures to include a notice on the labeling that states taking testosterone treatments can lead to possible increased risk of heart attacks and strokes. The FDA recommends that patients using testosterone should seek medical attention right away if they have these symptoms: